The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index; 5 of the 37 sources its claims cite were checked for support.
Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease
Open accessAbstract
Background Liposuction has been proposed as a potential treatment for the metabolic complications of obesity. We evaluated the effect of large-volume abdominal liposuction on metabolic risk factors for coronary heart disease in women with abdominal obesity. Methods We evaluated the insulin sensitivity of liver, skeletal muscle, and adipose tissue (with a euglycemic-hyperinsulinemic clamp procedure and isotope-tracer infusions) as well as levels of inflammatory mediators and other risk factors for coronary heart disease in 15 obese women before and 10 to 12 weeks after abdominal liposuction. Eight of the women had normal glucose tolerance (mean [+/-SD] body-mass index, 35.1+/-2.4), and seven had type 2 diabetes (body-mass index, 39.9+/-5.6). Results Liposuction decreased the volume of subcutaneous abdominal adipose tissue by 44 percent in the subjects with normal glucose tolerance and 28 percent in those with diabetes; those with normal oral glucose tolerance lost 9.1+/-3.7 kg of fat (18+/-3 percent decrease in total fat, P=0.002), and those with type 2 diabetes lost 10.5+/-3.3 kg of fat (19+/-2 percent decrease in total fat, P Conclusions Abdominal liposuction does not significantly improve obesity-associated metabolic abnormalities. Decreasing adipose tissue mass alone will not achieve the metabolic benefits of weight loss.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
5 of 37 cited sources checked · 3 supported · 0 flagged · accuracy not yet measured
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Even small amounts of weight loss induced by a negative energy balance affects many variables pertaining to body-fat composition and lipid metabolism -variables that probably contribute to the metabolic abnormalities associated with obesity.[22][23][24][25]”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > After Liposuction
What the sources say
- Not checked — no full text of the sourcecites [22] source
- Could not verifycites [23] sourceExperimental — accuracy not yet measured
The Rapid communication Abstract describes a cross-sectional study of intramyocellular lipids and insulin sensitivity in normal-weight adults; the Discussion addresses their correlation. Searches for weight loss, negative energy balance, and energy restriction found no passage saying that small weight losses affect body-fat composition or lipid metabolism. Page numbers were not provided in our copy. (LLM, conf=0.77)
- Not checked — no full text of the sourcecites [24] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesEvery source the paper cites for this claim was checked and supports it.
In the paper
“Weight loss decreases visceral fat mass, 26 intramyocellular fat, 27 intrahepatic fat, 28 fat-cell size, 29 and the rate of release of fatty acids from adipose tissue.30”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > After Liposuction
What the sources say
- Supportedcites [28] source
The Results section (‘Effects of weight loss on body composition and liver enzymes’) reports that liver fat decreased significantly after weight loss in both the high- and low-liver-fat groups. The claim is supported for the obese women studied. (LLM, conf=0.95)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Even small amounts of weight loss induced by a negative energy balance affects many variables pertaining to body-fat composition and lipid metabolism -variables that probably contribute to the metabolic abnormalities associated with obesity.[22][23][24][25]”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > After Liposuction
What the sources say
- Not checked — no full text of the sourcecites [22] source
- Supportedcites [23] source
The introductory passage links obesity with skeletal-muscle insulin resistance and says lipids could play an important role in that resistance. The Discussion reports that intramyocellular lipid stores and circulating fatty acids are associated with insulin sensitivity, supporting the citing sentence’s hedged claim about lipid-related variables and metabolic abnormalities. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [24] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The measured truncal fat-free mass, which included tissue fluid, increased from 24.5±2.7 kg to 27.4±3.0kg (P<0.001) in the two groups overall.”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > body composition
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, liposuction had no significant effects on other risk factors for coronary heart disease, including blood pressure; fasting plasma glucose, insulin, and lipid concentrations; and concentrations of plasma markers of inflammation and insulin resistance (C-reactive protein, tumor necrosis factor a , interleukin-6, and adiponectin).”
- Also stated in: § After Liposuction · plain
“in contrast, liposuction in our subjects did not significantly change the plasma concentrations of any of these markers.”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > After Liposuction
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § After Liposuction · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Rates of appearance of glucose, glycerol, and free fatty acid and the rate of disappearance of glucose during basal conditions and during each stage of the clamp procedure were not significantly different before and after liposuction in either group (Fig. 2 and 3).”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > substrate kinetics and insulin sensitivity
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“those with normal oral glucose tolerance lost 9.1±3.7 kg of fat (18±3 percent decrease in total fat, P=0.002)”
- Also stated in: § body composition · plain
“Ten to 12 weeks after surgery, the mass of body fat had decreased by 9.1±3.7 kg from baseline (18±3 percent of the total fat mass, P=0.002) in the subjects with normal oral glucose tolerance”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > Abstract
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Also stated in: § body composition · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Liposuction caused a decrease in waist circumference in both groups”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > circulating inflammatory mediators and other risk factors for coronary heart disease
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Liposuction decreased body weight and body-mass index (the weight in kilograms divided by the square of the height in meters) because of a marked decrease in body fat (Table 1).”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > body composition
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Liposuction also decreased plasma leptin concentrations in both groups”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > circulating inflammatory mediators and other risk factors for coronary heart disease
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes
- Probably not a substantial claim. 14
- It may state two separate claims as one. 14
- The quote only partly states this claim. 1
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Recent advances in liposuction techniques now make it possible to remove considerable amounts of subcutaneous adipose tissue.9”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > Abstract
What the sources say
- Could not verifycites [9] sourceExperimental — accuracy not yet measured
The Objectives and Measurements sections discuss classifying and measuring facial wrinkles, not liposuction. Searches for liposuction, subcutaneous fat removal, and suction lipectomy found no passage addressing whether recent techniques permit removal of considerable amounts of adipose tissue. (LLM, conf=0.76)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“Although both the abdominal subcutaneous fat mass and the visceral fat mass are associated with insulin resistance, 2”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > Abstract
What the sources say
- Supportedcites [2] source
The Abstract reports significant correlations between insulin-sensitivity measures and both subcutaneous abdominal and intraperitoneal fat mass in 39 healthy middle-aged men. The claim describes these as associations, without asserting that either fat compartment has an independent effect. (LLM, conf=0.93)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Insulin infusion during stage 1 caused the expected decreases in the rates of appearance of glucose, glycerol, and free fatty acids, and insulin infusion during stage 2 caused the expected increase in the rate of disappearance of glucose both in subjects with normal glucose tolerance and in those with type 2 diabetes (Fig. 2 and 3).”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > substrate kinetics and insulin sensitivity
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The decrease in measured fat mass was consistent with the amount of fat aspirated during liposuction; approximately 60 percent of the liposuction aspirate was composed of fat.”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > body composition
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Liposuction decreased the volume of subcutaneous abdominal adipose tissue by 44 percent in the subjects with normal glucose tolerance and 28 percent in those with diabetes”
- Also stated in: § body composition · plain
“Liposuction decreased the volume of subcutaneous abdominal adipose tissue by 44 percent in the subjects with normal glucose tolerance and 28 percent in those with diabetes, whereas the volumes of visceral adipose tissue and thigh adipose tissue did not change significantly (Fig. 1 and Table 1).”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § body composition · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the subjects with normal glucose tolerance, plasma insulin concentrations after liposuction were similar to those before liposuction for both stages 1 and 2 of the clamp procedure”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > substrate kinetics and insulin sensitivity
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one. The quote only partly states this claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“did not significantly alter plasma concentrations of C-reactive protein, interleukin-6, tumor necrosis factor a , and adiponectin”
- Also stated in: § circulating inflammatory mediators and other risk factors for coronary heart disease · plain
“but it did not significantly alter the concentrations of other circulating cytokines or of C-reactive protein (Table 3).”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > Abstract
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § circulating inflammatory mediators and other risk factors for coronary heart disease · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“whereas the volumes of visceral adipose tissue and thigh adipose tissue did not change significantly”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > body composition
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“However, successful long-term weight management is difficult to achieve, and the majority of obese persons who lose weight by implementing lifestyle changes regain their lost weight over time.3”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > Abstract
What the sources say
- Not checked — no full text of the sourcecites [3] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, abdominal liposuction provides a unique opportunity to evaluate the importance of subcutaneous abdominal fat in the pathogenesis of insulin resistance and in the risk of coronary heart disease in persons with abdominal obesity.”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > Abstract
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Rests on an assumption: It is not known whether one or both of the abdominal subcutaneous and visceral fat depots are actually involved in the pathogenesis of insulin resistance or whether they are simply associated with the metabolic complications of obesity.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“In six of them, the medications were not changed after the clamp procedure; in one, rosiglitazone (4 mg per day) was stopped, and glipizide and metformin were continued.”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > Evaluation after Liposuction
Strength:plain· not yet calibratedn = 7Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Weight stability was carefully maintained before and after liposuction to eliminate the confounding effects of changes in energy balance on the study end points.”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > substrate kinetics and insulin sensitivity
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The 10-to-12-week delay was intended to eliminate the confounding effects of postsurgical inflammation on our study end points.”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > Evaluation after Liposuction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“The decrease in body fat was greater than the total decrease in body weight, however, because of abdominal-tissue edema, which often persists for months after liposuction.16”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > body composition
What the sources say
- Not checked — no full text of the sourcecites [16] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“These insulin infusion rates result in plasma insulin concentrations that provide an optimal range for evaluating the effect of insulin on glucose production and lipolysis (stage 1) and on glucose disposal (stage 2).”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > Euglycemic-Hyperinsulinemic Clamp Protocol
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“This amount of weight loss usually results in marked improvement in the metabolic abnormalities associated with obesity and improves insulin sensitivity, 18 blood pressure, 19 and concentrations of serum lipids 20 and circulating markers”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > After Liposuction
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“All the subjects had had a stable weight (with fluctuations of not more than 2 percent of the body weight) for at least two months and had been sedentary (exercising for less than one hour per week) for at least six months before entering the study.”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > subjects
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The number of subjects to be enrolled was determined as the estimated number needed for the study to detect a statistically significant effect of liposuction on glucose kinetics with a power of at least 0.8, if the subjects had lost a similar amount of body fat by dieting.”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > statistical analysis
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Adipose tissue is now recognized as an important endocrine organ that produces several bioactive proteins, including interleukin-6, tumor necrosis factor a , and adiponectin.”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > After Liposuction
What the sources say
- Not checked — no full text of the sourcecites [32] source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Interleukin-6 and tumor necrosis factor a can cause insulin resistance and atherosclerosis by impairing insulin signaling, stimulating lipolysis and fatty acid release, increasing hepatic synthesis of C-reactive protein, and increasing systemic inflammation, [32][33][34]”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > After Liposuction
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“In contrast, liposuction removes sub-cutaneous abdominal fat and reduces the total number of body fat cells, without altering visceral fat mass, 31 the size of the remaining fat cells, 10 intramyocellular fat, or intrahepatic fat.”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > After Liposuction
What the sources say
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“In contrast, liposuction removes sub-cutaneous abdominal fat and reduces the total number of body fat cells, without altering visceral fat mass, 31 the size of the remaining fat cells, 10 intramyocellular fat, or intrahepatic fat.”
§ Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease > After Liposuction
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
It is not known whether one or both of the abdominal subcutaneous and visceral fat depots are actually involved in the pathogenesis of insulin resistance or whether they are simply associated with the metabolic complications of obesity.
“it is not known whether one or both of these fat depots are actually involved in the pathogenesis of insulin resistance or whether they are simply associated with the metabolic complications of obesity.”
The paper relies on this without support.
Diet-induced weight loss improves the metabolic complications of abdominal obesity.
“Diet-induced weight loss improves the metabolic complications of abdominal obesity.”
The paper relies on this without support.
Liposuction does not induce a negative energy balance.
“Our results suggest that induction of a negative energy balance, not simply a decrease in the mass of adipose tissue, is critical for achieving the metabolic benefits of weight loss.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The data from the present study and our earlier study demonstrate that liposuction does not result in short-term or long-term improvement in most of the key metabolic risk factors for CHD.”
From Long-term Effects of Large-volume Liposuction on Metabolic Risk Factors for Coronary Heart Disease (2008) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Our data demonstrated that removal of large amounts of abdominal subcutaneous adipose tissue (SAT) (~10 kg) did not improve CHD risk factors or insulin sensitivity when subjects were evaluated ~10 weeks after the liposuction procedure was performed.”
From Long-term Effects of Large-volume Liposuction on Metabolic Risk Factors for Coronary Heart Disease (2008) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“These long-term results are consistent with our findings obtained 10 weeks after large-volume liposuction (5) and make it unlikely that persistent postsurgical inflammation masked the metabolic benefits of liposuction that we reported previously.”
From Long-term Effects of Large-volume Liposuction on Metabolic Risk Factors for Coronary Heart Disease (2008) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“These long-term results are consistent with our findings obtained 10 weeks after large-volume liposuction (5) and make it unlikely that persistent postsurgical inflammation masked the metabolic benefits of liposuction that we reported previously.”
From Long-term Effects of Large-volume Liposuction on Metabolic Risk Factors for Coronary Heart Disease (2008) · cites this paper as [5]
In the citing paper
“The removal of subcutaneous fat by liposuction does not appear to produce beneficial metabolic changes (182).”
From Cardiac remodeling in obesity (2008) · cites this paper as [182]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Glucose-tracer dose conversions disagree
MinorThe priming dose gives 22.5 μmol for 4.1 mg of the glucose tracer. At that same conversion, the stated 0.46 mg infusion rate corresponds to about 2.5 μmol, not 0.25 μmol, per minute per kilogram.
“priming dose, 4.1 mg per kilogram [22.5 µmol per kilogram]”
“0.46 mg per minute per kilogram [0.25 µmol per minute per kilogram]”
Post-liposuction insulin variability is misconverted
MinorThe paper specifies a factor of 6 for converting insulin from μU/ml to pmol/liter. An SD of 6 μU/ml therefore converts to 36 pmol/liter, not the reported 48.
Reported 48 · recomputed 36
“stage 1 and 2 values after liposuction, 42±5 and 89±6 µU per milliliter [252±30 and 534±48 pmol per liter], respectively”
Triglyceride estimate lies outside its confidence interval
MinorFor the normal-glucose-tolerance group, the reported triglyceride change is −30 mg/dl, but its stated 95% confidence interval runs only from −22 to +2 mg/dl.
“| Triglycerides (mg/dl) | 151±79 | 121±58 | -30”
“(-22 to +2) | 0.11”
Citations
Cites
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Relation of Body Fat Distribution to Metabolic Complications of Obesity*
KISSEBAH, A. H., VYDELINGUM, N., MURRAY, R., EVANS, D. J., KALKHOFF, R. K., & ADAMS, P. W. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-2-254 · Cited by 1,909
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,730
INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT*
Steele, R. D. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb44923.x · Cited by 1,680
Adipose Tissue as an Endocrine Organ
Ahima, R. S., & Flier, J. S. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00301-5 · Cited by 1,608
Esposito, K., Pontillo, A., Di Palo, C., Giugliano, G., Masella, M., Marfella, R., & Giugliano, D. (2003) · JAMA · doi:10.1001/jama.289.14.1799 · Cited by 1,511
Boden, G., & Shulman, G. I. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.3.x · Cited by 1,300
Krssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264
Flagged first, then by citations
1 of the 43 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Horowitz JF, 1999, Am J Physiol, 276, E278
- Ballor DL, 1994, Int J Obes Relat Metab Disord, 18, 35
- Klein S, 1996, Am J Physiol, 270, E739
Cited by
Sorted by citations
Items 201–300 of 908
Reductions in cardiovascular risk after bariatric surgery
Benraouane, F., & Litwin, S. E. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32834b7fc4 · Cited by 64
Black, S. E., Mitchell, E. A., Freedson, P. S., Chipkin, S. R., & Braun, B. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00291.2005 · Cited by 63
Review of cardiovascular risk factors in women
Evangelista, O., & McLaughlin, M. A. (2009) · Gender Medicine · doi:10.1016/j.genm.2009.02.004 · Cited by 62
Metabolic complications of obesity: inflated or inflamed?
Chandalia, M., & Abate, N. I. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.10.004 · Cited by 59
The Effect of Obesity on Chronic Kidney Disease
Kopple, J. D., & Feroze, U. (2011) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2010.10.009 · Cited by 62
D’Andrea, F., Grella, R., Rizzo, M. R., Grella, E., Grella, R., Nicoletti, G., Barbieri, M., & Paolisso, G. (2005) · Aesthetic Plastic Surgery · doi:10.1007/s00266-005-0089-x · Cited by 61
Changes of insulin sensitivity and secretion after bariatric/metabolic surgery
Mingrone, G., & Cummings, D. E. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.05.013 · Cited by 64
Viewpoints on the Way to the Consensus Session
Iozzo, P. (2009) · Diabetes Care · doi:10.2337/dc09-s304 · Cited by 63
The Clinical Implications of Blood Adiponectin in Cardiometabolic Disorders
Chang, L., Huang, K., Wu, Y., Kao, H., Chen, C., Lai, L., Hwang, J., & Yang, W. (2009) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60079-6 · Cited by 60
Obesity and Inflammation: Lessons From Bariatric Surgery
Compher, C. W., & Badellino, K. O. (2008) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607108326070 · Cited by 60
Knudson, J. D., Dinçer, Ü. D., Dick, G. M., Shibata, H., Akahane, R., Saito, M., & Tune, J. D. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00244.2005 · Cited by 60
Pontiroli, A. E., Frigè, F., Paganelli, M., & Folli, F. B. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9626-4 · Cited by 60
Beals, J. W., Smith, G. I., Shankaran, M., Fuchs, A. G., Schweitzer, G. G., Yoshino, J., Field, T., Matthews, M. D., Nyangau, E., Morozov, D., et al. (2021) · Hepatology · doi:10.1002/hep.31822 · Cited by 64
Self-citationNon-Alcoholic Fatty Liver Disease: Is Bariatric Surgery the Answer?
Pillai, A. A., & Rinella, M. E. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.012 · Cited by 59
Polak, J., Kováčová, Z., Jaček, M., Klimčáková, E., Kováčiková, M., Šiklová, M., Kuda, O., Šebela, M., Samcová, E., & Štich, V. (2007) · Clinical Science · doi:10.1042/cs20060296 · Cited by 61
Gallagher, D., Heshka, S., Kelley, D. E., Thornton, J., Boxt, L., Pi-Sunyer, F. X., Patricio, J., Mancino, J., Clark, J. M., & the MRI Ancillary Study Group of the Look AHEAD Research Group (2014) · Diabetes Care · doi:10.2337/dc14-1585 · Cited by 59
Yarizadeh, H., Eftekhar, R., Anjom-Shoae, J., Speakman, J. R., & Djafarian, K. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa090 · Cited by 68
Stanley, T. L., & Grinspoon, S. K. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.12.005 · Cited by 59
Bittel, D. C., Bittel, A. J., Tuttle, L. J., Hastings, M. K., Commean, P. K., Mueller, M. J., Cade, W. T., & Sinacore, D. R. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.11.003 · Cited by 60
Main characteristics of metabolically obese normal weight and metabolically healthy obese phenotypes
Teixeira, T. F., Alves, R. D. M., Moreira, A. P. B., & Pelúzio, M. D. C. G. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuu007 · Cited by 61
Ybarra, J., Blanco‐Vaca, F., Fernandez, S., Castellví, A., Bonet, R., Palomer, X., Ordóñez‐Llanos, J., Trius, A., Vila-Rovira, R., & Pérez, A. (2008) · Obesity Surgery · doi:10.1007/s11695-007-9261-5 · Cited by 60
Dismantling weight stigma in eating disorder treatment: Next steps for the field
McEntee, M. L., Philip, S. R., & Phelan, S. M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1157594 · Cited by 69
WAJCHENBERG, B. L., Nery, M., Cunha, M. R., & da Silva, M. E. R. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200005 · Cited by 57
High Protein Diet and Metabolic Plasticity in Non-Alcoholic Fatty Liver Disease: Myths and Truths
Chiara, F. D., Checcllo, C. U., & Ramón‐Azcón, J. (2019) · Nutrients · doi:10.3390/nu11122985 · Cited by 58
Esteghamati, A., Alamdari, A., Zandieh, A., Elahi, S., Khalilzadeh, O., Nakhjavani, M., & Meysamie, A. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.11.003 · Cited by 56
Pescatori, L., Savarino, E. V., Mauri, G., Silvestri, E., Cariati, M., Sardanelli, F., & Sconfienza, L. M. (2019) · Radiologia Brasileira · doi:10.1590/0100-3984.2017.0211 · Cited by 55
Hordern, M., Cooney, L. M., Beller, E., Prins, J. B., Marwick, T. H., & Coombes, J. S. (2008) · Clinical Science · doi:10.1042/cs20070422 · Cited by 56
Busetto, L., Bassetto, F., Zocchi, M. L., Zuliani, F., Nolli, M. L., Pigozzo, S., Coin, A., Mazza, M., Sergi, G., Mazzoleni, F., et al. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.09.009 · Cited by 55
Accelerated Vascular Aging as a Paradigm for Hypertensive Vascular Disease: Prevention and Therapy
Barton, M., Husmann, M. J. W., & Meyer, M. R. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.062 · Cited by 52
Current treatment options for the metabolic syndrome
DEEDWANIA, P. C., & Волкова, Н. И. (2005) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-005-0007-1 · Cited by 54
Fat Distribution and Glucose Intolerance Among Greenland Inuit
Jørgensen, M. E., Borch‐Johnsen, K., Stolk, R. P., & Bjerregaard, P. (2013) · Diabetes Care · doi:10.2337/dc12-2703 · Cited by 51
Linke, A. H.-P., Sonnabend, M., Faßhauer, M., Höllriegel, R., Schuler, G. C., Niebauer, J., Stümvoll, M., & Blüher, M. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.11.026 · Cited by 53
Adipose tissue and the physiologic underpinnings of metabolic disease
O’Rourke, R. W. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.07.032 · Cited by 56
Mallipedhi, A., Prior, S. L., Barry, J. D., Caplin, S., BAXTER, J. N., & Stephens, J. W. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.04.019 · Cited by 53
The Obese Patient with Diabetes Mellitus: From Research Targets to Treatment Options
Sharma, A. M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.010 · Cited by 53
Insulin resistance and salt-sensitive hypertension in metabolic syndrome
Fujita, T. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm409 · Cited by 50
Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease
Hsu, C. C.-S., Ness, E. M., & Kowdley, K. V. (2017) · Advances in Nutrition · doi:10.3945/an.116.013730 · Cited by 53
Li, F., Zhang, G., Liang, J., et al. (2009) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-0997-1 · Cited by 51
Rizzo, M. R., Paolisso, G., Grella, R., Barbieri, M., Grella, R., Ragno, E., Grella, R., Nicoletti, G., & D’Andrea, F. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02337.x · Cited by 50
Kanety, H., Hemi, R., Ginsberg, S., Pariente, C., Yissachar, E., Barhod, E., Funahashi, T., & Laron, Z. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0419 · Cited by 49
Adipose tissue fatty acid metabolism and cardiovascular disease
Frayn, K. N., Fielding, B. A., & Karpe, F. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000171919.62129.6b · Cited by 52
Metabolic consequences of overfeeding in humans
Tappy, L. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200411000-00006 · Cited by 51
Ultrasonography for the evaluation of visceral fat and the metabolic syndrome
Meriño-Ibarra, E., Artieda, M., Cenarro, A., Goicoechea, J., Calvo, L., Guallar, A., & Civeira, F. (2005) · Metabolism · doi:10.1016/j.metabol.2005.04.009 · Cited by 50
Greater Omentectomy Improves Insulin Sensitivity in Nonobese Dogs
Lottati, M., Kolka, C. M., Stefanovski, D., Kirkman, E. L., & Bergman, R. N. (2009) · Obesity · doi:10.1038/oby.2008.642 · Cited by 51
Role of Obesity in Cardiomyopathy and Pulmonary Hypertension
Cruz, C. S. D., & Matthay, R. A. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.06.001 · Cited by 49
Omentectomy added to Roux-en-Y gastric bypass surgery: a randomized, controlled trial
Dillard, T. H., Purnell, J. Q., Smith, M. D., Raum, W. J., Hong, D., Laut, J., & Patterson, E. J. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.09.027 · Cited by 51
Body composition and cardiometabolic health: the need for novel concepts
Bosy‐Westphal, A., Braun, W., Geisler, C., Norman, K., & Müller, M. J. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0158-2 · Cited by 53
Small molecules for mesenchymal stem cell fate determination
Cheng, Y., Dong, J., & Bian, Q. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i12.1084 · Cited by 50
Daly, C., Hildebrandt, P. R., Bertrand, M. E., Ferrari, R., Remme, W. J., Simoons, M. L., & Fox, K. M. (2007) · Heart · doi:10.1136/hrt.2006.113084 · Cited by 50
Non-alcoholic fatty liver disease: From insulin resistance to mitochondrial dysfunction
Herruzo, J. A. S., Ruiz, I. G., Carreras, M. P., & Muñoz-Yagüe, M. T. (2006) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082006001100006 · Cited by 48
Traditional Anthropometric Parameters Still Predict Metabolic Disorders in Women With Severe Obesity
Ledoux, S., Coupaye, M., Essig, M., Msika, S., Roy, C., Quéguiner, I., Clérici, C., & Larger, É. (2009) · Obesity · doi:10.1038/oby.2009.349 · Cited by 49
Makimura, H., Feldpausch, M. N., Rope, A. M., Hemphill, L., Torriani, M., Lee, H., & Grinspoon, S. K. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2794 · Cited by 50
Tynan, G. A., Hearnden, C. H. A., Oleszycka, E., Lyons, C. L., Coutts, G., O’Connell, J., Corrigan, M. A., Lynch, L., Campbell, M., Callanan, J. J., et al. (2014) · Diabetes · doi:10.2337/db13-1476 · Cited by 49
Rega‐Kaun, G., Kaun, C., & Wojta, J. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-03-0212 · Cited by 46
Huffman, K. M., Slentz, C. A., Bales, C. W., Houmard, J. A., & Kraus, W. E. (2008) · Metabolism · doi:10.1016/j.metabol.2007.11.023 · Cited by 46
Decision Making in Abdominoplasty
Sözer, S. O., Agullo, F. J., Santillan, A. A., & Wolf, C. (2007) · Aesthetic Plastic Surgery · doi:10.1007/s00266-006-0148-y · Cited by 46
Obesity-Related Neuroinflammation: Magnetic Resonance and Microscopy Imaging of the Brain
Woo, A., Botta, A. M., Shi, S. S. W., Paus, T., & Pausová, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158790 · Cited by 47
Contribution of Adipose Tissue to Health Span and Longevity
Huffman, D. M., & Barzilai, N. (2010) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000319991 · Cited by 45
The blind men 'see' the elephant-the many faces of fatty liver disease
Girija, S. M. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.831 · Cited by 45
Understanding Adipose Tissue Dysfunction
Blüher, M. (2024) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes24013 · Cited by 55
Liu, J., Coady, S., Carr, J. J., Hoffmann, U., Taylor, H. A., & Fox, C. S. (2013) · Obesity · doi:10.1002/oby.20307 · Cited by 42
Crowther, N. J., Ferris, W. F., Ojwang, P., & Rheeder, P. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02505.x · Cited by 42
Independent tissue contributors to obesity-associated insulin resistance
Kusters, Y. H. A. M., Schalkwijk, C. G., Houben, A. J. H. M., Kooi, M. E., Lindeboom, L., Roodt, J. O. ’., Joris, P. J., Plat, J., Mensink, R. P., Barrett, E. J., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89695 · Cited by 43
Hoenig, M. E., Pach, N. M., Thomaseth, K., Le, A., Schaeffer, D. J., & Ferguson, D. C. (2013) · Obesity · doi:10.1002/oby.20306 · Cited by 43
Sdralis, E., Argentou, M., Mead, N., Kehagias, I., Alexandridis, T., & Kalfarentzos, F. E. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0925-z · Cited by 41
Emerging Concepts in the Medical and Surgical Treatment of Obesity
Aylwin, S. J. B., & Al-Zaman, Y. (2008) · Frontiers of hormone research · doi:10.1159/000115368 · Cited by 41
HANSEN, E., Hajri, T., & Abumrad, N. N. (2006) · Surgery · doi:10.1016/j.surg.2005.10.018 · Cited by 41
Relationship between body fat mass and bone metabolism
Holecki, M. T., & Więcek, A. (2010) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.969 · Cited by 39
What can bariatric surgery teach us about the pathophysiology of type 2 diabetes?
Andréelli, F., Amouyal, C., Magnan, C., & Mithieux, G. (2009) · Diabetes & Metabolism · doi:10.1016/s1262-3636(09)73456-1 · Cited by 42
Foster, M. T., Shi, H., Seeley, R. J., & Woods, S. C. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.05.014 · Cited by 40
Abdominal adiposity and liver fat content 3 and 12 months after gastric banding surgery
Heath, M. L., Kow, L., Slavotinek, J., Valentine, R., Toouli, J., & Thompson, C. H. (2009) · Metabolism · doi:10.1016/j.metabol.2008.05.021 · Cited by 38
Benatti, F. B. (2011) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s12143 · Cited by 39
Leptin and Coronary Heart Disease Risk: Prospective Case Control Study of British Women
Lawlor, D. A., Smith, G. D., Kelly, A., Sattar, N. A., & Ebrahim, S. B. J. (2007) · Obesity · doi:10.1038/oby.2007.202 · Cited by 38
Insulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM
Colosimo, S., Mitra, S. K., Chaudhury, T., & Marchesini, G. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111016 · Cited by 38
Stranahan, A. M., Guo, D., Yamamoto, M., Hernandez, C. M., Khodadadi, H., Baban, B., Zhi, W., Lei, Y., Lu, X., Ding, K., et al. (2022) · Diabetes · doi:10.2337/db22-0192 · Cited by 40
Seven, E., Thuesen, B. H., Linneberg, A. R., & Jeppesen, J. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07306 · Cited by 37
Keswell, D., Tootla, M., & Goedecke, J. H. (2016) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2015-088 · Cited by 37
Mitterberger, M. C., Mattesich, M., Klaver, E., Lechner, S., Engelhardt, T. O., Larcher, L., Pierer, G., Piza‐Katzer, H., & Zwerschke, W. (2010) · The Journals of Gerontology Series A · doi:10.1093/gerona/glq107 · Cited by 37
Adipokines and coronary vasomotor dysfunction.
Knudson, J. D., Dick, G. M., & Tune, J. D. (2007) · PubMed · Cited by 37
Is there a cardiomyopathy of obesity?
Owan, T., & Litwin, S. E. (2007) · Current Heart Failure Reports · doi:10.1007/s11897-007-0016-3 · Cited by 36
Gharib, S. A., Khalyfa, A., Abdelkarim, A., Ramesh, V., Buazza, M., Kaushal, N., Bhushan, B., & Gozal, D. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0830-7 · Cited by 39
Zaffina, C., Wyttenbach, R., Pagnamenta, A., Grasso, R. F., Biroli, M., Grande, F. D., & Rizzo, S. (2021) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-21-619 · Cited by 37
Adipokines--targeting a root cause of cardiometabolic risk
Bakhai, A. (2008) · QJM · doi:10.1093/qjmed/hcn066 · Cited by 37
Little evidence of systemic and adipose tissue inflammation in overweight individuals
Redman, L. M. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00058 · Cited by 35
Polak, J., Kovacova, Z., Holst, J. J., Verdich, C., Astrup, A. V., Blaak, E. E., Patel, K., Oppert, J., Langin, D., Martínez, J. A., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0512 · Cited by 34
Erlingsson, S., Herard, S., Leinhard, O. D., Lindström, T., Länne, T., Borga, M., & Nyström, F. H. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.028 · Cited by 34
Fisher, G., Hyatt, T. C., Hunter, G. R., Oster, R. A., Desmond, R. A., & Gower, B. A. (2011) · Obesity · doi:10.1038/oby.2011.85 · Cited by 33
Kanas, P. H. D., Sforzo, G. A., Boisseau, N., Pereira-Lancha, L. O., & Lancha, A. H. (2018) · Nutrition · doi:10.1016/j.nut.2018.09.027 · Cited by 33
Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes
Nobarani, S., Alaei-Shahmiri, F., Aghili, R., Malek, M., Poustchi, H., Lahouti, M., & Khamseh, M. E. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06953-z · Cited by 35
Impact of Large-Volume Liposuction on Serum Lipids in Orientals: A Pilot Study
Hong, Y. G., Kim, H. T., Seo, S. W., Chang, C. H., Rhee, E., & Lee, W. (2006) · Aesthetic Plastic Surgery · doi:10.1007/s00266-005-0010-7 · Cited by 32
Rattarasarn, C. (2006) · Acta Physiologica · doi:10.1111/j.1748-1716.2005.01521.x · Cited by 34
Ferrer‐Lorente, R., Béjar, M. T., & Badimón, L. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0070 · Cited by 35
Katsogiannos, P., Kamble, P. G., Boersma, G. J., Karlsson, F. A., Lundkvist, P., Sundbom, M., Pereira, M. J., & Eriksson, J. W. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02165 · Cited by 32
Metabolic Inflexibility in Skeletal Muscle: A Prelude to the Cardiometabolic Syndrome?
Thyfault, J. P., Rector, R. S., & Noland, R. C. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2006.05629.x · Cited by 31
Richey, J. M., Woolcott, O. O., Stefanovski, D., Harrison, L. N., Zheng, D., Lottati, M., Hsu, I. R., Kim, S. P., Kabir, M., Catalano, K. J., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90972.2008 · Cited by 32
Stehno‐Bittel, L. (2008) · Physical Therapy · doi:10.2522/ptj.20080034 · Cited by 32
Lower body subcutaneous fat accumulation and diabetes mellitus risk
Livingston, E. H. (2006) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2006.02.009 · Cited by 31
Metabolic Effects of Liposuction — Yes or No?
Esposito, K., Giugliano, G., & Giugliano, D. (2004) · New England Journal of Medicine · doi:10.1056/nejm200409233511320 · Cited by 31
Danilla, S., Longton, C., Valenzuela, K., Cavada, G., B, H. N., Tabilo, C., Erazo, C., Benítez, S., Sepulveda, S., Rosales, R. S., et al. (2013) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2013.07.001 · Cited by 29
McAuley, P. A., Hsu, F., Loman, K. K., Carr, J. J., Budoff, M. J., Szklo, M., Sharrett, A. R., & Ding, J. (2011) · Obesity · doi:10.1038/oby.2011.191 · Cited by 29
Metadata
- Authors
- Klein, S., Fontana, L., Young, V. L., Coggan, A. R., Kilo, C., Patterson, B. W., & Mohammed, B. S.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-06-17
- Volume
- 350
- Issue
- 25
- Pages
- 2549-2557
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1973382595
- Cited by
- 917
- References
- 43
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 16 · 2023: 21 · 2022: 25 · 2021: 24 · 2020: 22 · 2019: 24 · 2018: 36 · 2017: 27 · 2016: 24 · 2015: 44 · 2014: 38 · 2013: 38 · 2012: 39
- FWCI
- 67.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Funders
- National Institutes of Health (5p41rr000954-34)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK037948, P30DK056341)
- National Center for Research Resources (RR 00954, RR.00036)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD001459)
- Topics
- Health Sciences › Medicine › Surgery › Body Contouring and Surgery
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- liposuction, abdominal obesity, insulin sensitivity, coronary risk factors, type 2 diabetes, adipose tissue, glucose disposal, lipolysis, inflammatory mediators, C-reactive protein, interleukin-6, TNF-α, adiponectin, weight loss
- MeSH terms
- Abdomen, Adipose Tissue, Adult, Blood Glucose, Body Composition, Body Constitution, Cholesterol, Diabetes Mellitus, Type 2, Female, Humans, Insulin, Insulin Resistance, Liver, Middle Aged, Obesity, Risk Factors, Triglycerides, Lipectomy, Glucose Clamp Technique, Weight Loss, Body Mass Index, Muscle, Skeletal, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
